stockrowAMNEAL PHARMACEUTICALS, INC. (AMRX) vs Hims & Hers Health, Inc. (HIMS)
- AMNEAL PHARMACEUTICALS, INC. AMRX 19.41 −2.71%
- Hims & Hers Health, Inc. HIMS 24.11 −9.56%
AMNEAL PHARMACEUTICALS, INC. and Hims & Hers Health, Inc. are both Drug Manufacturers Specialty & Generic companies. AMNEAL PHARMACEUTICALS, INC. is the larger, with a market value of $6.8B against $5.6B — 1.2× the size. Hims & Hers Health, Inc. has negative trailing earnings, so its P/E is not meaningful; AMNEAL PHARMACEUTICALS, INC. trades at 36.9×. Hims & Hers Health, Inc. grew revenue faster over the last twelve months: 28.0% against 8.88%. AMNEAL PHARMACEUTICALS, INC. has the higher net margin (4.17% vs −5.51%) and the higher return on invested capital (8.45% vs −11.4%). Across the 19 metrics below, Hims & Hers Health, Inc. leads on 11 and AMNEAL PHARMACEUTICALS, INC. on 8.
Valuation
Profitability
| Metric | AMRX | HIMS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 40.24% | 68.43% | 53.51% |
| Operating margin | 14.99% | (5.99%) | 0.00% |
| Net margin | 4.17% | (5.51%) | (2.45%) |
| Free cash flow margin | (1.89%) | 3.22% | 0.00% |
| Return on equity | (53,107.17%) | (32.03%) | (0.80%) |
| Return on assets | 3.01% | (5.16%) | (1.67%) |
| Return on invested capital | 8.45% | (11.38%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack